Amylyx Pharmaceuticals, Inc.
Ticker: 1658551
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY24 | Q3 FY24 | Q2 FY24 | Q2 FY24 | Q1 FY24 | Q1 FY24 | Q3 FY23 | Q2 FY23 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.42+0.0% | 0.42+141.2% | -1.02+0.0% | -1.02-101.2% | 88.64+0.0% | 88.64-13.7% | 102.69+4.6% | 98.22 |
| Total Income | 0.42+0.0% | 0.42+141.2% | -1.02+0.0% | -1.02-101.2% | 88.64+0.0% | 88.64-13.7% | 102.69+4.6% | 98.22 |
| EXPENSES | ||||||||
| Expenditure | 76.08+0.0% | 76.08+1.1% | 75.26+0.0% | 75.26-64.3% | 210.77+0.0% | 210.77+151.0% | 83.97+7.6% | 78.02 |
| Tax | — | 0.00 | 0.00 | — | 0.24+0.0% | 0.24-84.2% | 1.52-21.2% | 1.93 |
| PROFIT | ||||||||
| PBT | -72.70+0.0% | -72.70+0.0% | -72.70+0.0% | -72.70+38.7% | -118.55+0.0% | -118.55-629.0% | 22.41-6.7% | 24.01 |
| Net Profit | -72.70+0.0% | -72.70+0.0% | -72.70+0.0% | -72.70+38.8% | -118.79+0.0% | -118.79-668.6% | 20.89-5.3% | 22.07 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00%-200.00pp | 100.00% | 100.00%+200.00pp | -100.00% | -100.00%-118.23pp | 18.23%-2.34pp | 20.57% |
| NPM % | -100.00% | -100.00%-200.00pp | 100.00% | 100.00%+200.00pp | -100.00% | -100.00%-120.34pp | 20.34%-2.13pp | 22.48% |
| EPS | -1.07+0.0% | -1.07+0.0% | -1.07+0.0% | -1.07+38.9% | -1.75+0.0% | -1.75-664.5% | 0.31-6.1% | 0.33 |
Corporate Events
Board MeetingAMLX
20264Jun
Board Meeting
Annual Meeting of Stockholders to vote on the election of Cl…
SEC Filing ↗